论文部分内容阅读
本文报告206例40岁以下青年人肺癌的综合治疗疗效及预后因素分析,结果表明全组1、3和5年生存率分别为40.3%、12.6%和6.3%。疗效以早期手术组为最佳,术后+放/和化疗组次之,单纯放、化和放化组为最差。影响青年人肺癌预后的主要因素是病理学类型、病期早晚及是否采用合理的综合治疗,但早期出现重要器官的转移是影响青年人肺癌预后的重要因素。因此,提高疗效的关键是要早期诊断,积极采用合理的综合治疗。
This article reports the comprehensive treatment efficacy and prognostic factors of 206 patients with lung cancer under 40 years old. The results show that the overall 1-, 3-, and 5-year survival rates were 40.3%, 12.6%, and 6.3%. The efficacy was best in the early surgery group, followed by the postoperative + radiotherapy/chemotherapy group, and the radiotherapy, chemotherapy, and radiochemotherapy group was the worst. The main factors affecting the prognosis of lung cancer in young people are the type of pathology, the early and late stage of the disease, and the rational use of comprehensive treatment. However, the early occurrence of metastasis of important organs is an important factor affecting the prognosis of young people with lung cancer. Therefore, the key to improving the therapeutic effect is to make early diagnosis and actively adopt rational comprehensive treatment.